Lang C N, Steinfurt J, Odening K E
Department of Cardiology and Angiology I, Heart Center University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Herz. 2017 Apr;42(2):162-170. doi: 10.1007/s00059-017-4549-2.
For the past few years, children affected by an inherited channelopathy have been counseled to avoid (recreational) sports activities and all competitive sports so as to prevent exercise-induced arrhythmia and sudden cardiac death. An increased understanding of the pathophysiological mechanisms, better anti-arrhythmic strategies, and, in particular, more epidemiological data on exercise-induced arrhythmia in active athletes with channelopathies have changed the universal recommendation of "no sports," leading to revised, less strict, and more differentiated guidelines (published by the American Heart Association/American College of Cardiology in 2015). In this review, we outline the disease- and genotype-specific mechanisms of exercise-induced arrhythmia; give an overview of trigger-, symptom-, and genotype-dependent guidance in sports activities for children with long QT syndrome (LQTS), Brugada syndrome (BrS), catecholaminergic polymorphic ventricular tachycardia (CPVT), or short QT syndrome (SQTS); and highlight the novelties in the current guidelines compared with previous versions. While it is still recommended for patients with LQT1 and CPVT (even when asymptomatic) and all symptomatic LQTS patients (independent of genotype) to avoid any competitive and high-intensity sports, other LQTS patients successfully treated with anti-arrhythmic therapies and phenotype-negative genotype-positive patients may be allowed to perform sports at different activity levels - provided they undergo regular, sophisticated evaluations to detect any changes in arrhythmogenic risk.
在过去几年里,患有遗传性离子通道病的儿童一直被建议避免(娱乐性)体育活动和所有竞技运动,以预防运动诱发的心律失常和心源性猝死。随着对病理生理机制的深入了解、更好的抗心律失常策略的出现,尤其是关于患有离子通道病的活跃运动员运动诱发心律失常的更多流行病学数据,改变了“禁止运动”这一普遍建议,从而产生了修订后更宽松、更具差异化的指南(由美国心脏协会/美国心脏病学会于2015年发布)。在本综述中,我们概述了运动诱发心律失常的疾病和基因型特异性机制;概述了针对长QT综合征(LQTS)、Brugada综合征(BrS)、儿茶酚胺能多形性室性心动过速(CPVT)或短QT综合征(SQTS)患儿,在体育活动中基于触发因素、症状和基因型的指导;并强调了当前指南与先前版本相比的新颖之处。虽然仍建议LQT1和CPVT患者(即使无症状)以及所有有症状的LQTS患者(无论基因型如何)避免任何竞技性和高强度运动,但其他经抗心律失常治疗成功的LQTS患者以及表型阴性基因型阳性患者,在进行定期、全面评估以检测致心律失常风险的任何变化的前提下,可能被允许进行不同活动水平的运动。